Neuropsychiatric Risks Linked to COVID-19 Revealed
New Nature study shows SARS2 significantly elevates the risk of neuropsychiatric conditions including anxiety, mood disorders, cognitive impairment and psychotic disorders for up to 6 months.
“Alarmingly, even individuals with mild or asymptomatic infections face elevated risk.”